Benefits of cartilage repair system persist after three years
This article was originally published in Clinica
Long-term studies have confirmed the benefits of using cells cultured from a patient's own cartilage to repair damaged cartilage on the end of the tibia at the knee. The results are published in the fifth report of Genzyme's cartilage repair registry, which follows the progress of patients treated with Carticel, the company's autologous cultured chondrocytes.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.